Physician profile
Salena Pho
NPI 1760451496
$1,564.02
in general payments reported to CMS, 2019-2025
16 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $456 · 2021: $203 · 2022: $121 · 2023: $55.59 · 2024: $91.25 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $336.27 | 2019-2020 | |
| Allergan, INC. | $317.41 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $222.51 | 2019-2021 | |
| Alcon Vision LLC | $218.04 | 2019-2025 | Clareon, Total30 |
| Oyster Point Pharma, INC. | $97.62 | 2023-2025 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $85.92 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $73.97 | 2024-2025 | Xdemvy |
| Abbvie INC. | $63.86 | 2025 | |
| Dompe US, INC. | $34.88 | 2025 | Oxervate |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $17.86 | 2023 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.13 | 2021 | |
| Shire North American Group INC | $14.75 | 2019 | |
| Sight Sciences, INC. | $14.72 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salena Pho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.